Advanced Biologic Drugs and Manufacturing Process
- 1st Edition - May 10, 2024
- Imprint: Academic Press
- Author: Basanta Kumara Behera
- Language: English
- Paperback ISBN:9 7 8 - 0 - 4 4 3 - 1 5 6 4 0 - 3
- eBook ISBN:9 7 8 - 0 - 4 4 3 - 1 5 6 4 1 - 0
Advanced Biologic Drugs and Manufacturing Process explains biologic drugs, their pharmaceutical charters, and their significance in curing life-threatening chronic diseases. It als… Read more
Purchase options
Institutional subscription on ScienceDirect
Request a sales quoteAdvanced Biologic Drugs and Manufacturing Process explains biologic drugs, their pharmaceutical charters, and their significance in curing life-threatening chronic diseases. It also provides the latest information on the use of biological drugs for the treatment of numerous diseases and conditions and their most advanced therapies available, including how biologics have impacted cancer therapy, delayed or reversed the course of immune-related conditions, and changed the lives of those with rare chronic diseases. In addition, the book explains how immunotherapy is used for the treatment of diseases by activating or suppressing the immune system.
Scientists working on the front lines in the biotechnology industry are provided with an overview on stable production processes and how to monitor the value chain transfer process of biologic drug for better return, in terms of profit. The book also helps researchers and academics on how to develop and update protocols related to testing, quality control, and quality assurance to obtain highly purified biopharmaceuticals or vaccines.
Scientists working on the front lines in the biotechnology industry are provided with an overview on stable production processes and how to monitor the value chain transfer process of biologic drug for better return, in terms of profit. The book also helps researchers and academics on how to develop and update protocols related to testing, quality control, and quality assurance to obtain highly purified biopharmaceuticals or vaccines.
- Gives insights into the conceptual strategic drive for manufacturing innovative, biologically derived therapeutic compounds to launch for commercial purposes
- Focuses on how to execute biopharmaceutical portfolio trends to bring sustainable manufacturing processes per the guidelines of international regulatory acts
- Highlights the emerging trends in medical sciences on tissue engineering, regenerative medicine, personalized medicines, and various innovative technique on immunotherapy to fight against life-threatening diseases
Scientists and industry professionals working on front lines in biotechnology and biopharmaceutical industries
- Cover image
- Title page
- Table of Contents
- Copyright
- About the author
- Chapter 1. Process initiation
- 1.1. Process initiation
- 1.2. Move toward innovative therapeutic
- 1.3. Biologic versus synthetic dugs
- 1.4. Why biologic drugs
- 1.5. Biologics classification
- 1.6. Stem cell therapy
- 1.7. Gene therapy
- 1.8. Biologic drugs from living resources
- 1.9. Preparation of antibody
- 1.10. Action of immune system on cancer agent
- 1.11. Large scale production of monoclonal antibodies
- Chapter 2. Regeneration medicine
- 2.1. Regeneration medicines
- 2.2. What are biomaterials
- 2.3. What is bioink
- 2.4. Type of bioprinters
- 2.5. 3D bioprinting process methods
- 2.6. 4D bioprinting
- 2.7. Selection of cell lines for bioprinting
- 2.8. Human tissue fabrication
- Chapter 3. Portfolio manage assignments
- 3.1. Strategic portfolio of biopharmaceutical companies
- 3.2. Types of investment strategies
- 3.3. Modern portfolio theory (MPT)
- 3.4. Driving the growth of portfolio-model use in biotechnology industry
- 3.5. Amendment in drug design for better delivery
- 3.6. Competitive market in therapeutic proteins
- Chapter 4. Immunotherapeutic proteins
- 4.1. Immunotherapeutic proteins
- 4.2. Pathway of immune system
- 4.3. Type of immunity
- 4.4. Components of immunity
- 4.5. History preview
- 4.6. Type of immune protein
- 4.7. Manufacture process
- 4.8. Current status
- 4.9. Future perspectives
- Chapter 5. Biologic from mammalian and non-mammalian cell lines
- 5.1. History
- 5.2. Biologic from mammalian cell lines
- 5.3. Future perspectives
- Chapter 6. Personalized medicine
- 6.1. Personalized medicine
- 6.2. Medicine and personalized medicine
- 6.3. Potential benefit of personalized medicine
- 6.4. Concept development
- 6.5. Personalized medicine challenges and opportunity
- 6.6. Global status of personalized medicine
- 6.7. Hurdles in personalized medicine implementation
- 6.8. Next generation sequencing (NGS) test and precision medicine
- 6.9. Application
- 6.10. FDA approval for personalized medicine
- 6.11. International property rights for personalized medicine
- Chapter 7. Bionanotechnology
- 7.1. Biologic drugs upgradation by nanotechnology
- 7.2. Significance of biological nanoparticles
- 7.3. Different between a molecule and nanoparticle
- 7.4. Nanoparticle biomolecule conjugate
- 7.5. Drug delivering through nanoparticle
- 7.6. Type of nanoparticle in drug delivery system
- 7.7. Role of biomolecules in nanoparticle formation
- 7.8. Conclusion
- Index
- Edition: 1
- Published: May 10, 2024
- Imprint: Academic Press
- No. of pages: 376
- Language: English
- Paperback ISBN: 9780443156403
- eBook ISBN: 9780443156410
BB
Basanta Kumara Behera
Dr. Basanta Kumara Behera was a Professor of Biotechnology at three distinguished Indian universities, where he taught and conducted research at the post-graduate level on medical biotechnology, biopharmaceutical, microbial process development, drug designing, bio-energy management, and biomass processing technology since 1978. In 2009, he joined an MNC company as an advisor for specialty chemicals production and drug design through microbial process technology. He is associated with national and international companies as a technical advisor to produce biopharmaceuticals under cGMP norms. Dr. Behera has authored and edited books with various publishers worldwide.
Affiliations and expertise
Former Director, Advanced Center for Biotechnology, Maharshi Dayanand University, Rohtak, Haryana, IndiaRead Advanced Biologic Drugs and Manufacturing Process on ScienceDirect